Metabolix (YTEN) Earns News Sentiment Score of 0.23
News articles about Metabolix (NASDAQ:YTEN) have been trending somewhat positive this week, Accern reports. Accern ranks the sentiment of news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Metabolix earned a media sentiment score of 0.23 on Accern’s scale. Accern also assigned news coverage about the specialty chemicals company an impact score of 45.0761133094681 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
Shares of Metabolix (NASDAQ:YTEN) traded down 1.57% on Monday, hitting $3.14. The stock had a trading volume of 1,651 shares. Metabolix has a 52 week low of $0.25 and a 52 week high of $9.03. The stock’s 50-day moving average price is $2.73 and its 200 day moving average price is $2.24. The company’s market cap is $10.85 million.
Metabolix (NASDAQ:YTEN) last posted its quarterly earnings results on Thursday, August 10th. The specialty chemicals company reported ($0.96) earnings per share for the quarter. Metabolix had a negative net margin of 190.57% and a negative return on equity of 145.04%. The business had revenue of $0.29 million during the quarter.
Yield10 Bioscience, Inc, formerly Metabolix, Inc, is an agricultural bioscience company. The Company is focused on developing disruptive technologies for step-change improvements in crop yield for food and feed crops to enhance global food security. By working on new approaches to improve fundamental elements of plant photosynthetic efficiency and optimizing carbon metabolism to direct more carbon to seed production, the Company is advancing several yield traits it has developed in crops, such as Camelina, canola, soybean and corn.
Receive News & Stock Ratings for Metabolix Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metabolix Inc. and related stocks with our FREE daily email newsletter.